Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-023886

Chairman and CEO bought 13,000 shares at an average $1.25 ($16,235)

From the SEC's structured data for this filing

Trades in this filing

Niihara Yutaka · Chairman and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-04-03 Purchase : show line 1 in the form +6,200 $1.24 $7,688 10,568,243 D
2020-04-06 Purchase : show line 2 in the form +4,700 $1.26 $5,922 10,572,943 D
2020-04-07 Purchase : show line 3 in the form +2,100 $1.25 $2,625 10,575,043 D
Open-market purchases · 13,000 sh · avg $1.25 · $16,235
Loading xslF345X03/doc4.xml…